| Financial Year |
March 31 2023 |
| Monetary Funds |
5,658,404.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
21,545,733.51 |
| Advances to Suppliers |
10,175,079.53 |
| Other Receivables |
111,590,611.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
226,907,910.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,013,288.89 |
| Other Current Assets |
42,349,492.26 |
| Total Current Assets |
422,240,521.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
47,754,003.39 |
| Investment Properties |
556,361,678.62 |
| Fixed Assetes |
524,365,362.47 |
| Under-construction Projects |
31,513,801.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,507,620.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
32,229,472.75 |
| Other Non-Current Assets |
1,095,088.03 |
| Sub-Total of Non-Current Assets |
1,268,554,107.77 |
| Total Assets |
1,690,794,629.11 |
| Short-Term Loans |
277,703,401.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
128,896,799.45 |
| Accounts Received In Advance |
4,041,236.85 |
| Employee Compensation Payable |
15,595,398.69 |
| Taxes Payable |
4,191,918.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
385,346,731.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,096,719.68 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
938,393,867.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
46,014,234.26 |
| Deferred Income Tax Liabilities |
2,387,299.97 |
| Other Non-Current Liabilities |
65,330,011.55 |
| Sub-Total of Non-Current Liabilities |
125,059,680.92 |
| Total Liabilities |
1,063,453,548.24 |
| Paid-In Capital(Or Share Stock) |
929,017,761.00 |
| Capital Surplus |
51,259,534.18 |
| Surplus Reserve |
77,898,985.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-427,265,852.76 |
| Minority Stockholder's Interest |
22,384,099.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
604,956,981.20 |
| Owner's Equity（Stockholder's Equity） |
627,341,080.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,690,794,629.11 |
